Skip to main content
Top
Published in: Annals of General Psychiatry 1/2019

Open Access 01-12-2019 | Suicide | Case report

Critical appraisal of major depression with suicidal ideation

Author: Maurizio Pompili

Published in: Annals of General Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

Regardless of its nature, suicidal ideation, in the absence of another diagnosis, is quintessentially associated with major clinical depression. Although for the characteristics of being depressed it is reasonable to have some wish to die, there is no real attempt to understanding the suicidal mind. Clinicians are therefore often inclined to consider suicidal ideation a symptom of major depression. Yet, most depressed patients do not die by suicide, and many of them never experience suicidal ideation even in the most severe depressing scenario. At a closer look, when one works with suicidal individual, suicide appears complex and not line with the obsolete medical model. There are often warning signs for suicide, and suicidal individuals experience mental pain as a common denominator of many adverse events.

Case presentation

A case report of an entrepreneur with no previous psychiatric history describes the process of meditating suicide as a dimension overlapping the depressive disorder. Details of how this 63-year-old male developed high suicide risk are reported, and clinicians are guided into the understanding of suicide risk.

Conclusions

Nowadays, clinicians are requested to provide an in-depth investigation into the suicidal mind, an assessment adjunctive to the psychiatric evaluation. A phenomenological approach may be the key to unlock the suicidal mind. Clinicians may use such tool in light of the need for the empathic understanding of human suffering as well as a paradigm shift in the care of suicidal individuals.
Literature
1.
go back to reference Esquirol JE. Des maladies mentales considérées sous les rapports médicals, hygiéniques et médico-légal (Vol. 1), Paris, J.B. Baillière. 1838, p. 639 [English translation by Hunt KE, entitled Mental Maladies: treatise on insanity [Philadelphia, 1845]. Esquirol JE. Des maladies mentales considérées sous les rapports médicals, hygiéniques et médico-légal (Vol. 1), Paris, J.B. Baillière. 1838, p. 639 [English translation by Hunt KE, entitled Mental Maladies: treatise on insanity [Philadelphia, 1845].
2.
go back to reference Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157:1925–32.CrossRef Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157:1925–32.CrossRef
3.
go back to reference Stone DM, Simon TR, Fowler KA, et al. Vital signs: trends in state suicide rates—United States, 1999–2016 and circumstances contributing to suicide—27 states, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:617–24.CrossRef Stone DM, Simon TR, Fowler KA, et al. Vital signs: trends in state suicide rates—United States, 1999–2016 and circumstances contributing to suicide—27 states, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:617–24.CrossRef
5.
go back to reference Ahrens B, Müller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001;34:132–6.CrossRef Ahrens B, Müller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001;34:132–6.CrossRef
6.
go back to reference Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ. Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175:327–35.CrossRef Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ. Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175:327–35.CrossRef
7.
go back to reference Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry. 2016;77:719–25.CrossRef Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry. 2016;77:719–25.CrossRef
8.
go back to reference Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA Jr, Sanacora G. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2018;175:150–8.CrossRef Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA Jr, Sanacora G. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2018;175:150–8.CrossRef
9.
go back to reference Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial [InterSePT]. Arch Gen Psychiatry. 2003;60:82–91.CrossRef Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial [InterSePT]. Arch Gen Psychiatry. 2003;60:82–91.CrossRef
10.
go back to reference Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry. 1995;152:183–90.CrossRef Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry. 1995;152:183–90.CrossRef
11.
go back to reference Reid WH, Mason M, Hogan T. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv. 1998;49:1029–33.CrossRef Reid WH, Mason M, Hogan T. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv. 1998;49:1029–33.CrossRef
12.
go back to reference Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:671–7.CrossRef Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:671–7.CrossRef
13.
go back to reference Pompili M, Baldessarini RJ, Tondo L, Innamorati M, Tatarelli R, Girardi P, De Pisa E. Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients. J Affect Disord. 2010;122:154–8.CrossRef Pompili M, Baldessarini RJ, Tondo L, Innamorati M, Tatarelli R, Girardi P, De Pisa E. Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients. J Affect Disord. 2010;122:154–8.CrossRef
14.
go back to reference Courtet P, Jaussent I, Lopez-Castroman J, Gorwood P. Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients. Eur Neuropsychopharmacol. 2014;24:1650–815.CrossRef Courtet P, Jaussent I, Lopez-Castroman J, Gorwood P. Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients. Eur Neuropsychopharmacol. 2014;24:1650–815.CrossRef
15.
go back to reference Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science. 2003;302(5643):290–2.CrossRef Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science. 2003;302(5643):290–2.CrossRef
16.
go back to reference Maj M. When does depression become a mental disorder? Br J Psychiatry. 2011;199:85–6.CrossRef Maj M. When does depression become a mental disorder? Br J Psychiatry. 2011;199:85–6.CrossRef
17.
go back to reference Maj M. “Clinical judgment” and the DSM-5 diagnosis of major depression. World Psychiatry. 2013;12:89–91.CrossRef Maj M. “Clinical judgment” and the DSM-5 diagnosis of major depression. World Psychiatry. 2013;12:89–91.CrossRef
18.
go back to reference American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington: American Psychiatric Publishing; 2013.CrossRef American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington: American Psychiatric Publishing; 2013.CrossRef
19.
20.
go back to reference Weisman AD. Is suicide a disease? Life Threat Behav. 1971;1:219–31. Weisman AD. Is suicide a disease? Life Threat Behav. 1971;1:219–31.
21.
go back to reference Pompili M, Belvederi Murri M, Patti S, Innamorati M, Lester D, Girardi P, Amore M. The communication of suicidal intentions: a meta-analysis. Psychol Med. 2016;46:2239–53.CrossRef Pompili M, Belvederi Murri M, Patti S, Innamorati M, Lester D, Girardi P, Amore M. The communication of suicidal intentions: a meta-analysis. Psychol Med. 2016;46:2239–53.CrossRef
22.
go back to reference Jobes DA. Collaborating to prevent suicide: a clinical-research perspective. Suicide Life Threat Behav. 2000;30(1):8–17.PubMed Jobes DA. Collaborating to prevent suicide: a clinical-research perspective. Suicide Life Threat Behav. 2000;30(1):8–17.PubMed
23.
go back to reference Vieta E, Grunze H, Azorin JM, Fagiolini A. Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: results from the IMPACT self-reported online survey. J Affect Disord. 2014;156:206–13.CrossRef Vieta E, Grunze H, Azorin JM, Fagiolini A. Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: results from the IMPACT self-reported online survey. J Affect Disord. 2014;156:206–13.CrossRef
25.
go back to reference Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985;142:559–63.CrossRef Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985;142:559–63.CrossRef
26.
go back to reference Booij L, Wang D, Lévesque ML, Tremblay RE, Szyf M. Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120251.CrossRef Booij L, Wang D, Lévesque ML, Tremblay RE, Szyf M. Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120251.CrossRef
27.
go back to reference Turecki G, Ernst C, Jollant F, Labonté B, Mechawar N. The neurodevelopmental origins of suicidal behavior. Trends Neurosci. 2012;35(1):14–23.CrossRef Turecki G, Ernst C, Jollant F, Labonté B, Mechawar N. The neurodevelopmental origins of suicidal behavior. Trends Neurosci. 2012;35(1):14–23.CrossRef
28.
go back to reference Opel N, Redlich R, Dohm K, Zaremba D, Goltermann J, Repple J, Kaehler C, Grotegerd D, Leehr EJ, Böhnlein J, Förster K, Meinert S, Enneking V, Sindermann L, Dzvonyar F, Emden D, Leenings R, Winter N, Hahn T, Kugel H, Heindel W, Buhlmann U, Baune BT, Arolt V, Dannlowski U. Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study. Lancet Psychiatry. 2019;6:318–26.CrossRef Opel N, Redlich R, Dohm K, Zaremba D, Goltermann J, Repple J, Kaehler C, Grotegerd D, Leehr EJ, Böhnlein J, Förster K, Meinert S, Enneking V, Sindermann L, Dzvonyar F, Emden D, Leenings R, Winter N, Hahn T, Kugel H, Heindel W, Buhlmann U, Baune BT, Arolt V, Dannlowski U. Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study. Lancet Psychiatry. 2019;6:318–26.CrossRef
29.
go back to reference Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Transl Psychiatry. 2016;6:e799.CrossRef Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Transl Psychiatry. 2016;6:e799.CrossRef
Metadata
Title
Critical appraisal of major depression with suicidal ideation
Author
Maurizio Pompili
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2019
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-019-0232-8

Other articles of this Issue 1/2019

Annals of General Psychiatry 1/2019 Go to the issue